Walorski introduced the Safeguarding Women's and Children's Health Act of 2022 this month to ensure that complications caused by the abortion pill are accurately documented. The legislation would require abortion pill complications to be reported to both the pill's manufacturer and the FDA. Currently, abortion businesses only need to report adverse events to the abortion pill's manufacturer. The manufacturer can then report those events to the FDA, but it is only required to report deaths.
Only 28 states require abortion businesses to report complications directly to the government.
“As chemical abortions become more frequent, American women need to know the risks of abortion pills such as mifepristone. While the Biden Administration’s FDA recklessly removes guardrails on chemical abortion drug prescribing, too many of the facts are unknown. Women who take abortion drugs are ending up in emergency rooms – or worse,” Walorski said.
There is currently an upward trend of prescribing women abortion pills without first examining them to verify the gestational age of the child or if there are any rare pregnancy conditions. If the child is past the gestational age at which the abortion pill regimen is designed to work, attempting the abortion pill regimen could pose major medical risks. The same would be true if the mother had an undiagnosed ectopic pregnancy. This is especially risky if the woman attempts this kind of abortion while home alone, which is also increasingly common.
